Some cancers respond well to immunotherapy, a medication therapy that prompts the immune system to target tumours, although results against lung cancer have been conflicting.
Louisiana [US], May 9 (ANI): According to new research, scientists are working to improve immune checkpoint inhibitors to better target tumours and reduce their impact on healthy tissues.